PRESBYTERIAN ST. LUKES MEDICAL CENT
1. Target Overview & Investment Thesis
PRESBYTERIAN ST. LUKES MEDICAL CENT is a 287-bed safety-net/medicaid heavy in nan, CO with $646.0M in net patient revenue and a 27.6% operating margin. The hospital serves a payer mix of 12.3% Medicare, 42.4% Medicaid, and 45.3% commercial.
Thesis: Platform Growth. Our ML models identify $47.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 27.6% to 35.0% (+736bps).
| Net Revenue HCRIS | $646.0M |
| Current EBITDA COMPUTED | $178.6M |
| Operating Margin COMPUTED | 27.6% |
| Occupancy HCRIS | 75.8% |
| Revenue / Bed COMPUTED | $2.3M |
| Net-to-Gross HCRIS | 12.8% |
| Distress Probability ML | 48.2% |
2. Market Context & Competitive Position
CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 27.6% places it above the state median. Among 21 size-comparable peers (144-574 beds), the median margin is 1.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (144-574), prioritizing same-state peers. 21 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PRESBYTERIAN ST. LUKES MEDICAL (Target) | CO | 287 | $646.0M | 27.6% |
| CHILDRENS HOSPITAL COLORADO | CO | 486 | $1.42B | -2.3% |
| MEMORIAL HEALTH SYSTEM | CO | 501 | $1.11B | 3.5% |
| DENVER HEALTH MEDICAL CENTER | CO | 396 | $1.11B | -8.1% |
| CENTURA PENROSE HOSPITAL | CO | 484 | $809.7M | 0.2% |
| POUDRE VALLEY HOSPITAL | CO | 218 | $722.4M | 10.8% |
| SWEDISH MEDICAL CENTER | CO | 351 | $670.0M | 23.8% |
| SAINT JOSEPH HOSPITAL | CO | 400 | $567.5M | -6.1% |
| ST. MARYS HOSPITAL & MEDICAL C | CO | 237 | $554.0M | -11.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $47.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $13.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $12.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $12.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $7.9M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $413K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $178.6M |
| + RCM Uplift | +$47.6M |
| Pro Forma EBITDA | $226.1M |
| Current Margin | 27.6% |
| Pro Forma Margin | 35.0% |
| WC Released (1x) | $24.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $274.7M | $1.65B | 6.02x | 43.2% |
| Base (11x exit) | 10.0x | 11.0x | $274.7M | $1.91B | 6.95x | 47.3% |
| Bull Case | 9.0x | 11.0x | $247.3M | $2.15B | 8.71x | 54.2% |
| Bull (12x exit) | 9.0x | 12.0x | $247.3M | $2.42B | 9.80x | 57.9% |
| Bear Case | 11.0x | 10.0x | $302.2M | $1.33B | 4.39x | 34.4% |
| Bear (11x exit) | 11.0x | 11.0x | $302.2M | $1.56B | 5.15x | 38.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (42.4%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 21 hospitals with 144-574 beds
- Same-state prioritization (n=22)
- Comp margins: P25=-8.1% / P50=1.2% / P75=10.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.